Tenascin-C orchestrates an immune suppressive tumor microenvironment in oral squamous cell carcinoma - Archive ouverte HAL
Article Dans Une Revue Cancer Immunology Research Année : 2020

Tenascin-C orchestrates an immune suppressive tumor microenvironment in oral squamous cell carcinoma

Thomas Loustau
Romain Veber
Matthias Mörgelin
Abdouramane Camara
  • Fonction : Auteur
  • PersonId : 1060039
Sebastian Schaub
Uwe Hansen
  • Fonction : Auteur
Nicodème Paul
Raphael Carapito
  • Fonction : Auteur
  • PersonId : 838247
Hélène Dumortier
Katja Schenke-Layland
  • Fonction : Auteur
Anne Sudaka
Gertraud Orend
  • Fonction : Auteur
  • PersonId : 1057325

Résumé

Inherent immune suppression represents a major challenge in the treatment of human cancer. The extracellular matrix molecule tenascin-C promotes cancer by multiple mechanisms, yet the roles of tenascin-C in tumor immunity are incompletely understood. Using a 4NQO-induced oral squamous cell carcinoma (OSCC) model with abundant and absent tenascin-C, we demonstrated that tenascin-C enforced an immune suppressive lymphoid stroma via CCL21/CCR7 signaling, leading to increased metastatic tumors. Through TLR4, tenascin-C increased expression of CCR7 in CD11c+ myeloid cells. By inducing CCL21 in lymphatic endothelial cells via integrin α9β1 and binding to CCL21, tenascin-C immobilized CD11c+ cells in the stroma. Inversion of the lymph node-to-tumor CCL21 gradient, recruitment of T regulatory cells, high expression of anti-inflammatory cytokines and matrisomal components were hallmarks of the tenascin-C-instructed lymphoid stroma. Ablation of tenascin-C or CCR7 blockade inhibited the lymphoid immune suppressive stromal properties, reducing tumor growth, progression and metastasis. Thus, targeting CCR7 could be relevant in human head and neck tumors as high tenascin-C expression and an immune suppressive stroma correlate to poor patient survival.
Fichier principal
Vignette du fichier
Spenle, Cancer Immunology Res, 2020.pdf (1.88 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02902040 , version 1 (09-10-2020)

Identifiants

Citer

Caroline Spenlé, Thomas Loustau, Devadarssen Murdamoothoo, William Erne, Stéphanie Beghelli-de La Forest Divonne, et al.. Tenascin-C orchestrates an immune suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunology Research, 2020, 8 (9), pp.1122-1138. ⟨10.1158/2326-6066.CIR-20-0074⟩. ⟨hal-02902040⟩
604 Consultations
792 Téléchargements

Altmetric

Partager

More